Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis

S.-C. Bae,Y.H. Lee

Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis

2019

S.-C. Bae
Y.H. Lee

Objective This study systemically reviewed the evidence regarding the association between plasminogen activator inhibitor‑1 (PAI‑1) 4G/5G polymorphism and susceptibility to systemic lupus erythematous (SLE)/lupus nephritis (LN) and rheumatoid arthritis (RA) and the relationship between circulating PAI‑1 levels and SLE/LN and RA.

Keywords:

Lupus nephritis
Matrix metalloproteinase
Plasminogen activator inhibitor-1
Lupus erythematosus
Systemic lupus erythematosus
Rheumatoid arthritis
Medicine
Polymorphism (computer science)
Pathology
Immunology
Plasminogen activator
Odds ratio
Gastroenterology
Case-control study
Internal medicine
Dominance (genetics)
Rheumatology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations